PATENT CLAIM ANALYSIS

Application Number: 16135428
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "275000"]

Abstract:
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.

Claim (Index 21):
A compound of the formula: wherein: Ar is group of formula: R is aryl substituted with one or more halogen; R1, R2, and R3 are hydrogen; Ra is hydrogen, halogen, nitro, NHCOR4or NR5R6; Rb is hydrogen, nitro, NR5R6, OR7, or R8R9N\u2014C 1 -C 6  alkyl; R4 is hydrogen, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, NR5R6, OR7, SR7, R8R9N\u2014C 1 -C 6  alkyl, R8O\u2014C 1 -C 6  alkyl, an optionally further substituted straight or branched C 1 -C 6  alkyl, C 3 -C 6  cycloalkyl, heterocyclyl, aryl or heteroaryl; R5 and R6 are independently hydrogen, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, R8R9N\u2014C 2 -C 6  alkyl, R8O\u2014C 2 -C 6  alkyl, an optionally further substituted straight or branched C 1 -C 6  alkyl, C 3 -C 6  cycloalkyl, heterocyclyl, aryl or heteroaryl; or R5 and R6, taken together with the nitrogen atom to which they are bonded, form an optionally substituted heterocyclyl group; R7 is hydrogen, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, SOR10, SO 2 R10, R8R9N\u2014C 2 -C 6  alkyl, R8O\u2014C 2 -C 6  alkyl, an optionally further substituted straight or branched C 1 -C 6  alkyl, C 3 -C 6  cycloalkyl, heterocyclyl, aryl or heteroaryl; R8 and R9 are independently hydrogen, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, an optionally further substituted straight or branched C 1 -C 6  alkyl, C 3 -C 6  cycloalkyl, heterocyclyl, aryl or heteroaryl; or R8 and R9, taken together with the nitrogen atom to which they are bonded, may form an optionally substituted heterocyclyl group; and R10 is hydrogen, C 2 -C 6  alkenyl, C 2 -C 6  alkynyl, an optionally further substituted straight or branched C 1 -C 6  alkyl, C 3 -C 6  cycloalkyl, heterocyclyl, aryl, or heteroaryl; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14212256', '12668745', '13611679', '13140208', '12520387']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8512916157578845
- 35 USC 102 Novelty (BERT): 0.638298055529286
- Combined Prediction Score: 0.8299922597350247
- Mean Citation Score: 611.9929
- Max Citation Score: 649.7441
- Similarity Product: 538.3511547676861

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test